Drugs that contain Dienogest; Estradiol Valerate
1. Natazia patents expiration
NATAZIA's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6884793 | BAYER HLTHCARE | Combination preparation for contraception based on natural estrogens |
Oct, 2016
(7 years ago) | |
| US6133251 | BAYER HLTHCARE | Combination compound for contraception based on natural estrogen |
Oct, 2016
(7 years ago) | |
| US8071577 | BAYER HLTHCARE | Multi-phase contraceptive preparation based on a natural estrogen |
May, 2026
(2 years from now) | |
| US8153616 | BAYER HLTHCARE | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
Jan, 2028
(3 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication(I-648) | Mar 14, 2015 |
| New Product(NP) | May 06, 2013 |
Market Authorisation Date: 06 May, 2010
Treatment: Prevention of pregnancy; Treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception
Dosage: TABLET;ORAL
How can I launch a generic of NATAZIA before it's drug patent expiration?
More Information on Dosage
NATAZIA family patents
